rs752373714
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_000260.4(MYO7A):c.5243C>T(p.Thr1748Met) variant causes a missense change. The variant allele was found at a frequency of 0.00000903 in 1,550,336 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.5243C>T | p.Thr1748Met | missense_variant | Exon 38 of 49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.5129C>T | p.Thr1710Met | missense_variant | Exon 38 of 49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.5096C>T | p.Thr1699Met | missense_variant | Exon 39 of 50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.2669C>T | p.Thr890Met | missense_variant | Exon 18 of 29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.3083C>T | non_coding_transcript_exon_variant | Exon 21 of 32 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000129 AC: 2AN: 154812Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 82460
GnomAD4 exome AF: 0.00000930 AC: 13AN: 1398098Hom.: 0 Cov.: 31 AF XY: 0.00000580 AC XY: 4AN XY: 689756
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Thr1748Met variant in MYO7A has not been previously reported in individual s with hearing loss or Usher syndrome. This variant has been identified in 1/789 6 South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac .broadinstitute.org; dbSNP rs752373714); however, this frequency in the general population is not high enough to rule out a pathogenic role. Computational predi ction tools and conservation analyses do not provide strong support for or again st an impact to the protein. In summary, the clinical significance of the p.Thr 1748Met variant is uncertain. -
MYO7A-related disorder Uncertain:1
The MYO7A c.5243C>T variant is predicted to result in the amino acid substitution p.Thr1748Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.013% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-76914179-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 1748 of the MYO7A protein (p.Thr1748Met). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with MYO7A-related conditions. ClinVar contains an entry for this variant (Variation ID: 505218). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at